Clinical trial EV-301
An Open-Label, Randomized Phase 3 Study to Evaluate Enfortumab Vedotin vs Chemotherapy in Subjects with Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
Cancers | |
---|---|
Organ | Ureters - bladder - urethra |
Trial status | Trial closed for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | Astellas |
EudraCT Identifier | 2017-003344-21 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03474107 |
Inclusion criteria | Progression or relapse with anti-PD1 or anti-PD-L1 and platinum-based chemotherapy for locally advanced or metastatic urothelial carcinoma. |
Last update |